Catalyst Wire Dossier Catalyst Wire Dossier

Glycopyrronium and Formoterol Fumarate (GFF) MDI

glycopyrronium bromide; formoterol fumarate dihydrate · Pearl Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glycopyrronium and Formoterol Fumarate (GFF) MDI, covering 2016-12-23 to 2016-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD [Phase 3]

See pricing